A prevaccination validated network that drives the breadth of the protective neutralizing antibody response following Dengue Vaccine TV003 immunization

Adam Nicolas Pelletier, Gabriela Sanchez, Mark Watson, Abdullah Izmirly, Tiziana Di Pucchio, Elias Haddad, Eustache Paramithiotis, Jorge Khalil, Michael Diamond, Esper Kallas, Rafick Pierre Sekaly
doi: https://doi.org/10.1101/2021.09.25.21264123

Article Information

doi 
https://doi.org/10.1101/2021.09.25.21264123
History 
  • September 28, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Adam Nicolas Pelletier1,
  2. Gabriela Sanchez2,
  3. Mark Watson3,
  4. Abdullah Izmirly4,
  5. Tiziana Di Pucchio2,
  6. Elias Haddad4,
  7. Eustache Paramithiotis3,
  8. Jorge Khalil5,
  9. Michael Diamond6,
  10. Esper Kallas5 and
  11. Rafick Pierre Sekaly2,*
  1. 1RPM Bioinfo Solutions;
  2. 2Emory University;
  3. 3CellCarta;
  4. 4Drexxel University;
  5. 5University of Sao Paulo;
  6. 6Washington University School of Medicine
  1. ↵* Corresponding author; email: rafick.sekaly{at}emory.edu
Back to top
Posted September 28, 2021.
Download PDF
Data/Code
Email
A prevaccination validated network that drives the breadth of the protective neutralizing antibody response following Dengue Vaccine TV003 immunization
Adam Nicolas Pelletier, Gabriela Sanchez, Mark Watson, Abdullah Izmirly, Tiziana Di Pucchio, Elias Haddad, Eustache Paramithiotis, Jorge Khalil, Michael Diamond, Esper Kallas, Rafick Pierre Sekaly
medRxiv 2021.09.25.21264123; doi: https://doi.org/10.1101/2021.09.25.21264123
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area